Microbial Drug Resistance

Scope & Guideline

Illuminating the Path to Effective Antimicrobial Strategies

Introduction

Explore the comprehensive scope of Microbial Drug Resistance through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Microbial Drug Resistance in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1076-6294
PublisherMARY ANN LIEBERT, INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1995 to 2024
AbbreviationMICROB DRUG RESIST / Microb. Drug Resist.
Frequency10 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801

Aims and Scopes

The journal 'Microbial Drug Resistance' focuses on the multifaceted aspects of drug resistance in microorganisms, particularly how these resistances affect treatment options and public health. The journal aims to disseminate research that enhances the understanding of microbial resistance mechanisms, epidemiology, and the development of novel therapeutic strategies.
  1. Mechanisms of Drug Resistance:
    Research articles explore the genetic, biochemical, and physiological mechanisms by which bacteria and fungi develop resistance to antimicrobial agents, including beta-lactams, macrolides, and newer antibiotics.
  2. Clinical Implications of Resistance:
    The journal emphasizes studies that investigate the clinical consequences of antimicrobial resistance, including treatment failures, infection outcomes, and the implications for public health.
  3. Surveillance and Epidemiology:
    Publications include epidemiological studies that track the prevalence and distribution of resistance genes in various environments, including hospitals, communities, and animal populations.
  4. Novel Therapeutic Approaches:
    Research on new antimicrobial agents, combination therapies, and alternative treatment strategies is a key focus, showcasing efforts to combat resistance in clinical settings.
  5. Environmental and One Health Perspectives:
    The journal also covers studies that assess the environmental impact of resistant pathogens and the interconnectedness of human, animal, and environmental health in the context of antimicrobial resistance.
The journal has identified several emerging themes that reflect the current challenges and advancements in the field of microbial drug resistance. These trends indicate a shift towards more complex and integrative approaches to understanding and combating resistance.
  1. Characterization of Resistance Genes and Mobile Elements:
    There is a growing emphasis on the characterization of resistance genes, particularly those located on mobile genetic elements such as plasmids, which facilitate the spread of resistance across different bacterial species.
  2. Impact of COVID-19 on Resistance Trends:
    Research examining how the COVID-19 pandemic has influenced antimicrobial resistance patterns, treatment practices, and infection control measures has gained significant attention.
  3. Use of Advanced Genomic Techniques:
    The application of whole-genome sequencing and other genomic techniques to analyze resistance mechanisms and track outbreaks is becoming increasingly prevalent in published studies.
  4. Environmental Resistance Dynamics:
    Emerging research focuses on the dynamics of antimicrobial resistance in environmental contexts, including wastewater, agricultural settings, and wildlife, highlighting the importance of a One Health approach.
  5. Innovative Therapeutic Strategies:
    There is a rising interest in exploring novel therapeutic strategies, including the use of bacteriophages, antimicrobial peptides, and combination therapies, to overcome drug resistance.

Declining or Waning

While the journal continues to focus on critical themes related to microbial drug resistance, certain areas of research have seen a decline in prominence over the recent publication years. These waning themes may reflect shifts in research priorities or advancements in understanding that have made some topics less central to ongoing discourse.
  1. Antibiotic Stewardship in Specific Settings:
    Although antibiotic stewardship remains important, there has been a noticeable decline in studies focusing solely on stewardship practices within specific healthcare settings, as more comprehensive and integrated approaches are being adopted.
  2. Basic Laboratory Techniques for Resistance Detection:
    Research centered around traditional laboratory methods for detecting resistance, such as disk diffusion or standard broth microdilution, appears to be less frequent, as newer molecular and rapid testing methods gain traction.
  3. Single-Pathogen Studies:
    The trend has shifted towards multi-pathogen studies and broader environmental assessments, leading to a decrease in publications focusing exclusively on single-pathogen resistance profiles.
  4. Global Surveys of Resistance Patterns:
    While still relevant, the frequency of global surveys of resistance patterns has diminished, possibly due to the increasing focus on localized studies that address specific regional challenges.

Similar Journals

Infection and Drug Resistance

Illuminating the path to effective therapeutic interventions.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6973Frequency: 1 issue/year

Infection and Drug Resistance, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to the critical fields of infectious diseases and pharmacology. Since its establishment in 2008, this journal has emerged as a vital resource for researchers, professionals, and students alike, offering thorough insights into the mechanisms of drug resistance and the effectiveness of various therapeutic interventions. With an impressive 2023 impact factor placing it in the Q2 category across multiple relevant disciplines, including Infectious Diseases and Pharmacology, it serves as a significant platform for high-quality research dissemination. Infection and Drug Resistance aims to foster a deeper understanding of the evolving challenges in managing infectious diseases and enhancing drug efficacy, contributing to the global discourse on public health. The journal's commitment to open access ensures that vital knowledge is readily available to promote broader scholarly engagement and innovation.

New Microbes and New Infections

Innovating solutions for a healthier tomorrow through microbial research.
Publisher: ELSEVIER SCI LTDISSN: Frequency: 6 issues/year

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

Revista Espanola de Quimioterapia

Innovating Solutions in Microbiology and Pharmacology
Publisher: SOCIEDAD ESPANOLA QUIMIOTERAPIAISSN: 0214-3429Frequency: 6 issues/year

The Revista Espanola de Quimioterapia, published by the SOCIEDAD ESPANOLA QUIMIOTERAPIA, is a pivotal open-access journal that has been advancing the field of clinical microbiology and pharmacology since its inception in 1989. With an E-ISSN of 1988-9518, this journal caters to a diverse audience of researchers, healthcare professionals, and students, providing them with critical insights into the latest developments in medicinal chemistry and therapeutic strategies. Located in Madrid, Spain, the journal reflects the rigorous academic standards of its associated institutions, contributing significantly to the translation of research into clinical practice. Achieving a Q3 ranking in the fields of Medicine, Microbiology, and Pharmacology in 2023 attests to its growing influence and relevance in the scientific community, making it a vital resource for those engaged in the quest for innovative solutions to pressing healthcare challenges. The journal prides itself on its commitment to maintaining an open-access model since 2018, ensuring that vital research is freely accessible to foster greater knowledge sharing and collaboration within the global scientific community.

mSphere

Advancing microbial insights for a brighter tomorrow.
Publisher: AMER SOC MICROBIOLOGYISSN: Frequency: 6 issues/year

mSphere is a leading open-access journal published by the American Society for Microbiology, dedicated to the dynamic fields of Microbiology and Molecular Biology. Since its inception in 2016, mSphere has rapidly established itself as a reputable source of scholarly research, achieving notable impact factors and excellence within the academic community. The journal ranks in the top quartile (Q1) amongst its peers in Microbiology, and Q2 in the field of Molecular Biology, demonstrating its significance and relevance through Scopus rankings—specifically, it holds the #42 spot out of 182 in the Microbiology category and #108 out of 410 in Molecular Biology. With an editorial commitment to advancing the understanding of microbial and molecular sciences, mSphere provides an accessible platform for researchers, professionals, and students alike to disseminate groundbreaking findings. The journal promotes rigorous peer-review and invites innovative contributions aimed at enhancing microbial research mobility and molecular exploration. Accessible openly since 2016, mSphere continues to thrive as an influential publication driving scientific dialogue and discovery in the microbiological sciences.

MIKROBIYOLOJI BULTENI

Pioneering Insights in Immunology and Microbiology
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

BMC MICROBIOLOGY

Fostering collaboration in the ever-evolving field of microbiology.
Publisher: BMCISSN: 1471-2180Frequency: 1 issue/year

BMC Microbiology is a leading open access journal published by BMC, dedicated to advancing the field of microbiology since its inception in 2001. With an ISSN of 1471-2180, this journal provides a vital platform for researchers, professionals, and students to share and access high-quality research and innovation in both general and medical microbiology. Based in the United Kingdom, BMC Microbiology holds a commendable Q2 ranking in both various microbiological categories according to the 2023 Scopus rankings, indicating its strong influence in the microbiological community, with a rank of #47 out of 140 in Medical Microbiology and #62 out of 182 in general Microbiology. The journal's commitment to open access ensures that groundbreaking research is freely available to facilitate collaboration and knowledge sharing among the global community of microbiologists. With a focus on publishing original research, reviews, and case studies, BMC Microbiology plays a critical role in disseminating information that can impact health and environmental conditions around the world.

Lancet Microbe

Unleashing Insights into Virology and Beyond
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

The Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.

International Journal of Microbiology

Innovating Solutions in Medical, Agricultural, and Environmental Microbiology
Publisher: HINDAWI LTDISSN: 1687-918XFrequency: 1 issue/year

Welcome to the International Journal of Microbiology, a premier platform dedicated to the dissemination of cutting-edge research in the field of microbiology. Published by HINDAWI LTD, this open-access journal has been making significant strides since its inception in 2009, ensuring that high-quality research is accessible to all. Situated in Egypt, the journal caters to an international audience, fostering collaboration across borders. With a commendable impact factor and recognized in the Q2 category for both general and medical microbiology, it ranks 48th out of 182 and 40th out of 140, respectively, according to Scopus statistics, placing it among the top-tier journals in its field. The International Journal of Microbiology publishes articles that explore various aspects of microbiology, from fundamental studies to applied research, thus contributing significantly to advancements in medical, agricultural, and environmental microbiology. This journal is an essential resource for researchers, professionals, and students eager to stay at the forefront of microbiological studies and their applications.

Mediterranean Journal of Infection Microbes and Antimicrobials

Advancing knowledge in infection and microbiology.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

INDIAN JOURNAL OF MICROBIOLOGY

Shaping the Future of Microbiology Research
Publisher: SPRINGERISSN: 0046-8991Frequency: 4 issues/year

INDIAN JOURNAL OF MICROBIOLOGY, published by Springer, serves as a vital platform for the dissemination of cutting-edge research in the field of microbiology. With an ISSN of 0046-8991 and an E-ISSN of 0973-7715, this esteemed journal invites contributions that span various disciplines within microbiology, encompassing both fundamental studies and applied research that can impact health, environment, and industry. Recognized in the Q3 category in Microbiology for 2023, and ranking #80 out of 182 in Scopus’ Microbiology category, it reflects its commitment to quality and significance in the academic community. Authors and researchers benefit from the journal's comprehensive review process, which enhances the visibility and reach of their work. While no open access options are currently offered, the INDIAN JOURNAL OF MICROBIOLOGY remains a premier choice for those aiming to contribute to the ongoing dialogue in microbiological studies, ensuring that knowledge continues to evolve and thrive.